M Bayliss1, C Miltenburger, M White, L Alvares. 1. QualityMetric, OptumInsight, 34 Albion Road, Bldg 400, Lincoln, RI 02865, USA. mbayliss@qualitymetric.com
Abstract
UNLABELLED: This paper presents a multi-method research project to develop a conceptual framework for measuring outcomes in studies of osteoporotic kyphosis. The research involved literature research and qualitative interviews among clinicians who treat patients with kyphosis and among patients with the condition. INTRODUCTION: Kyphosis due to at least one vertebral compression fracture is prevalent among osteoporotic patients, resulting in well-documented symptoms and impact on functioning and well-being. A three-part study led to development of a conceptual measurement framework for comprehensive assessment of symptoms, impact, and treatment benefit for kyphosis. METHODS: A literature-based disease model (DM) was developed and tested with physicians (n = 10) and patients (n = 10), and FDA guidelines were used to develop a final disease model and a conceptual framework. RESULTS: The DM included signs, symptoms, causes/triggers, exacerbations, and functional status associated with kyphosis. The DM was largely confirmed, but physicians and patients added several concepts related to impact on functioning, and some concepts were not confirmed and removed from the DM. CONCLUSIONS: This study confirms the need for more comprehensive assessment of health outcomes in kyphosis, as most current studies omit key concepts.
UNLABELLED: This paper presents a multi-method research project to develop a conceptual framework for measuring outcomes in studies of osteoporotic kyphosis. The research involved literature research and qualitative interviews among clinicians who treat patients with kyphosis and among patients with the condition. INTRODUCTION:Kyphosis due to at least one vertebral compression fracture is prevalent among osteoporoticpatients, resulting in well-documented symptoms and impact on functioning and well-being. A three-part study led to development of a conceptual measurement framework for comprehensive assessment of symptoms, impact, and treatment benefit for kyphosis. METHODS: A literature-based disease model (DM) was developed and tested with physicians (n = 10) and patients (n = 10), and FDA guidelines were used to develop a final disease model and a conceptual framework. RESULTS: The DM included signs, symptoms, causes/triggers, exacerbations, and functional status associated with kyphosis. The DM was largely confirmed, but physicians and patients added several concepts related to impact on functioning, and some concepts were not confirmed and removed from the DM. CONCLUSIONS: This study confirms the need for more comprehensive assessment of health outcomes in kyphosis, as most current studies omit key concepts.
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-10 Impact factor: 5.725
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-13 Impact factor: 5.725
Authors: Mehrsheed Sinaki; Michael Pfeifer; Elisabeth Preisinger; Eiji Itoi; René Rizzoli; Steven Boonen; Piet Geusens; Helmut W Minne Journal: Curr Osteoporos Rep Date: 2010-09 Impact factor: 5.096
Authors: Margaret L Rothman; Philippe Beltran; Joseph C Cappelleri; Joseph Lipscomb; Bonnie Teschendorf Journal: Value Health Date: 2007 Nov-Dec Impact factor: 5.725
Authors: W B Katzman; E Vittinghoff; F Lin; A Schafer; R K Long; S Wong; A Gladin; B Fan; B Allaire; D M Kado; N E Lane Journal: Osteoporos Int Date: 2017-07-08 Impact factor: 4.507
Authors: Wendy B Katzman; Eric Vittinghoff; Deborah M Kado; Anne L Schafer; Shirley S Wong; Amy Gladin; Nancy E Lane Journal: Phys Ther Date: 2015-08-06
Authors: Wendy B Katzman; Dana Miller-Martinez; Lynn M Marshall; Nancy E Lane; Deborah M Kado Journal: BMC Musculoskelet Disord Date: 2014-01-16 Impact factor: 2.362